Biomedicalization and the Embodied Self: Mechanisms of Medical Authority in Breast Cancer Management
DOI:
https://doi.org/10.63883/ijsrisjournal.v4i4.426Abstract
Drawing on biopower and embodiment, the article examines how biomedical authority in breast cancer care is produced through technologies (mammography, genetic testing, advanced imaging), institutional hierarchies, and standardized protocols. These mechanisms expand surveillance from disease to risk, privilege visual/objective evidence over lived sensation, and convert informed consent into procedure, narrowing autonomy. The analysis conceptualizes breast cancer as an embodied disruption: treatments reconfigure appearance, sexuality, and intimacy, generating body alienation and identity dissonance; reconstruction sits ambivalently between self-recovery and biomedical normalization. Yet agency persists. Individually, patients seek second opinions, combine complementary practices with conventional care, and cultivate “epistemic agency” via self-education. Collectively, advocacy networks mobilize narratives and lobby for integrative, patient-centered models that rebalance psychosocial with clinical outcomes. The article’s contribution is to link biomedicalization to identity work and to delineate “structural coercion” whereby choice is constrained within guideline-driven menus. It calls for care arrangements that retain the benefits of standardization while institutionalizing dialogic consent, legitimizing embodied testimony, and broadening success metrics beyond survival toward quality, dignity, and control.
Keywords : biomedicalization; embodiment; biopower; patient autonomy; standardized protocols; structural coercion; breast cancer.
Received Date: July 19, 2025
Accepted Date: August 11, 2025
Published Date: August 30, 2025
Available Online at https://www.ijsrisjournal.com/index.php/ojsfiles/article/view/426
Downloads
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.